Memantine Cf

Memantine Hydrochloride, the active ingredient in Memantine Cf, is a NMDA receptor antagonist presented as a tablet for oral use. It is used to treat cognitive symptoms of Alzheimer’s disease in adult patients. The medication works by modulating glutamate activity, helping to reduce excitotoxic neuronal damage associated with disease progression.

GNH USA supplies Memantine Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Memantine, an NMDA receptor antagonist, is used in the management of Alzheimer’s disease by modulating glutamate‑mediated neuronal activity.

Alzheimer’s disease (moderate to severe): improves cognition, memory, and daily functioning in patients with moderate to severe disease. Behavioral symptoms of Alzheimer’s disease: may reduce agitation, aggression, and other neuropsychiatric manifestations associated with the condition.

Memantine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Constipation: reduced bowel movements or difficulty passing stool. - Fatigue: feeling unusually tired or lacking energy.

Serious or Rare Side Effects: - Seizures: occurrence of convulsive episodes, especially in predisposed individuals. - Severe allergic reactions (e.g., Stevens‑Johnson syndrome): skin rash, blistering, or mucosal involvement. - Hepatic dysfunction: signs of liver injury such as jaundice, elevated enzymes, or abdominal discomfort.

When prescribing memantine, clinicians should consider several safety considerations.

Renal impairment: adjust dose or monitor renal function. Hepatic impairment: use with caution in patients with liver disease. History of seizures: monitor for increased seizure activity. Concomitant NMDA antagonists: avoid combining with other NMDA blockers. Elderly patients: start at low dose and titrate slowly. Store at below 25°C: keep in original packaging, protect from moisture.

Memantine can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase neurotoxicity. - Dextromethorphan: combined NMDA blockade can cause enhanced CNS depression. - Ketamine: concurrent use may lead to excessive NMDA inhibition.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase memantine plasma levels by reducing renal clearance. - NSAIDs: may increase risk of renal impairment when used together. - Anticholinergic agents: may diminish cognitive benefits of memantine.